Overview
This rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism is an extremely rare condition that affects multiple body systems from birth. The hallmark feature is congenital hypogonadotropic hypogonadism, which means the brain does not produce enough of the hormones (called gonadotropins) needed to trigger normal sexual development and puberty. Because the condition is multisystemic, it can also affect other organs and body functions beyond the reproductive system, potentially including the nervous system, skeleton, kidneys, heart, or other areas depending on the specific underlying cause. Patients may first come to medical attention due to delayed or absent puberty, underdeveloped genitalia at birth (such as micropenis or undescended testes in boys), or a reduced or absent sense of smell (anosmia), which is sometimes associated with these conditions. Additional features can vary widely and may include intellectual disability, hearing loss, skeletal abnormalities, heart defects, or kidney problems. The combination of hypogonadotropic hypogonadism with involvement of other organ systems helps distinguish this condition from isolated forms of hormone deficiency. Treatment is primarily supportive and symptom-based. Hormone replacement therapy is a cornerstone of management, helping to induce puberty and maintain normal hormone levels throughout life. Other treatments depend on which organ systems are affected and may include surgeries, physical therapy, hearing aids, or other interventions. A team of specialists is usually needed to provide comprehensive care. Early diagnosis and treatment can significantly improve quality of life and long-term outcomes.
Key symptoms:
Delayed or absent pubertyUnderdeveloped genitalia at birthUndescended testes in boysReduced or absent sense of smellShort stature or growth delaysSkeletal abnormalitiesHearing lossHeart defectsKidney abnormalitiesIntellectual disability or learning difficultiesLow energy or fatigueInfertilityVision problemsDental abnormalities
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism.
Community
No community posts yet. Be the first to share your experience with Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism.
Start the conversation →Latest news about Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism
No recent news articles for Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific gene or genes are responsible for my (or my child's) condition?,What hormone treatments are recommended, and what are the potential side effects?,Which other organ systems should be checked, and how often do we need follow-up testing?,What are the options for fertility in the future?,Are there any clinical trials or new treatments being studied for this condition?,What developmental or educational support services should we look into?,Should other family members be tested for this condition?
Common questions about Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism
What is Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism?
This rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism is an extremely rare condition that affects multiple body systems from birth. The hallmark feature is congenital hypogonadotropic hypogonadism, which means the brain does not produce enough of the hormones (called gonadotropins) needed to trigger normal sexual development and puberty. Because the condition is multisystemic, it can also affect other organs and body functions beyond the reproductive system, potentially including the nervous system, skeleton, kidneys, heart, or other areas depending on
At what age does Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism typically begin?
Typical onset of Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism is neonatal. Age of onset can vary across affected individuals.